Mayumi Ishida

Mayumi Ishida

Auto-generated profile, based on publicly available information

Mayumi Ishida

Departments of Psycho-Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2021 in European Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
HOHideki Onishi
Hideki Onishi
ISIzumi Sato
Izumi Sato
NUNozomu Uchida
Nozomu Uchida
TTTakao Takahashi
Takao Takahashi
DFDaisuke Furuya
Daisuke Furuya
MIMayumi Ishida
Mayumi Ishida
Background/Objectives: Recent studies have revealed thiamine deficiency (TD) as a cause of delirium in cancer patients. However, the extent to which Wernicke encephalopathy is present and in what patients is not well understood. Subjects/Methods: In this retrospective descriptive study, we investigated referred cancer patients who were diagnosed with delirium by a psycho-oncologist to clarify the proportion of TD, the therapeutic effect of thiamine administration, and the factors involved in its onset. Results: Among 71 patients diagnosed with delirium by a psycho-oncologist, TD was found in 45% of the patients. Intravenous administration of thiamine led to a recovery in about 60% of these patients. We explored the factors associated with TD using a multivariable regression model with a Markov chain Monte Carlo imputation procedure. We found an association between TD and chemotherapy (adjusted odds ratio, 1.98 [95% confidence interval, 1.04–3.77]); however, there were no significant associations between TD and the other factors we considered. Conclusions: TD is not particularly rare in delirium patients undergoing psychiatric consultation. The delirium was resolved in more than half of these patients by intravenous administration of thiamine. Oncologists should consider TD as a cause of delirium in cancer patients. Further prospective study is needed to clarify the relationship between TD and delirium in cancer patients.

1 June 2015
Verified
Conference Paper
Closed access
SYS. Yamagiwa
S. Yamagiwa
MIM. Ishida
M. Ishida
TKT. Kawano
T. Kawano
We report a flexible thin-film device, which consists of an array of microelectrode/waveguide stacked `optrodes' for optogenetic applications. Each electrode/waveguide-site enables simultaneous optical stimulation and electrical recording of neurons in the same alignment. Based on the calculations of the optical properties, we fabricated parylene-C(clad)/N(core)/C(clad) 18-μm-thick waveguides and confirmed the light propagation through the waveguides. The microelectrode embedded waveguide array shows the light propagation through the electrode exposed site, while the electrode exhibits the impedance of <; 2 kΩ at 1 kHz for neural recordings. These results indicate that the proposed flexible thin-film parylene-optrode array can be used for numerous biological tissues with a curvature, including brain and spinal cord.

1 January 1990 in Journal of Turbomachinery
Verified
Journal Article
Closed access
PDF file
MIM. Ishida
M. Ishida
YSY. Senoo
Y. Senoo
HUH. Ueki
H. Ueki
The velocity distribution was measured at the exit of two different types of un-shrouded centrifugal impeller under four different tip clearance conditions each; one with 20 radial blades and inducers and the other with 16 backward-leaning blades. The effect of tip clearance on input power was also measured. By increasing the tip clearance, the input power was hardly changed in the radial blade impeller and was reduced in the backward-leaning blade impeller. The velocity distribution normalized by the passage width between hub and shroud wall was hardly changed at the exit of the radial blade impeller by varying the tip clearance. On the other hand, the relative flow angle was reduced significantly and monotonously by an increase of tip clearance in the backward-leaning blade impeller. The change in input power due to the tip clearance was clearly related to the change of flow pattern at the exit of impeller due to the secondary flow. This is most likely caused by the component, normal to the blade, of the shear force to support the fluid in the clearance space against the pressure gradient in the meridional plane without blades.

7 September 2020 in European Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
AYAkira Yoshioka
Akira Yoshioka
ISIzumi Sato
Izumi Sato
HOHideki Onishi
Hideki Onishi
MIMayumi Ishida
Mayumi Ishida
Despite the fact that both thiamine deficiency (TD) and Wernicke encephalopathy (WE) have been observed to some degree in cancer patients, such cases of TD and/or WE reported to date have all been diagnosed after the initiation of treatment. We here report a case of TD that presented without the commonly accepted triad of WE symptoms based on a total nutritional evaluation prior to the onset of treatment for cancer. The patient was a 71-year-old man with esophageal cancer who was referred to the oncology outpatient clinic for evaluation to determine the treatment plan. Although he did not present with delirium, cerebellar signs, or ocular symptoms, TD was suspected based on a reduction in appetite lasting 2 months as thiamine stores in the body are depleted in as few as 18 days. Blood findings showed a marked decline in serum thiamine level supported, which the diagnosis of TD. This case revealed the existence of a cancer patient with subclinical TD prior to the onset of treatment for cancer. Due to the fact that TD can occur without the characteristic symptoms as in this case, we believe it is important that total nutritional evaluation of cancer patients always be considered.

6 January 2022 in CEN Case Reports
Verified
Journal Article
Closed access
PDF file
NSNayuta Seto
Nayuta Seto
MIMayumi Ishida
Mayumi Ishida
THTatsuya Hamano
Tatsuya Hamano
HOHideki Onishi
Hideki Onishi
NUNozomu Uchida
Nozomu Uchida

23 June 2023 in Palliative and Supportive Care
Verified
Journal Article
Closed access
PDF file
RSRyota Sato
Ryota Sato
MIMayumi Ishida
Mayumi Ishida
NUNozomu Uchida
Nozomu Uchida
TSTakehiko Sakimoto
Takehiko Sakimoto
TYTakefumi Yamaguchi
Takefumi Yamaguchi
HOHideki Onishi
Hideki Onishi
Objectives: Opioid analgesics play a central role in cancer pain treatment; however, it has been reported that opioid-induced constipation (OIC) develops in 80% of patients using opioid analgesics and leads to a decrease in quality of life. Naldemedine improves constipation without affecting the analgesic action of opioid analgesics via peripheral μ-opioid receptors.Methods: We report a terminally ill cancer patient who was diagnosed with opioid withdrawal syndrome (OWS) based on symptoms centered around restlessness and sweating that developed 43 days after administration of naldemedine for OIC.Results: The patient was a 78-year-old woman who was diagnosed with stage IVB uterine sarcoma in October, 1 year prior to her visit to our clinic, and underwent chemotherapy after surgery, but the disease became progressive. Thereafter, metastasis to the fourth thoracic vertebrae (Th4) was identified, and loxoprofen and acetaminophen were started for pain at the metastatic site. Oxycodone hydrochloride hydrate 10 mg/day was additionally administered on postoperative day 11, followed by naldemedine 0.2 mg/day for OIC. On the 43rd day after administration, the patient began to wander the hospital ward in a wheelchair and became noticeably restless. OWS due to naldemedine administration was suspected, and naldemedine was discontinued. The symptoms improved 7 days later, and no similar symptoms were observed thereafter.Significance of results: Patients receiving palliative care often exhibit psychiatric symptoms such as anxiety and depression, but OWS due to naldemedine should also be considered as a potential cause.